Skip to main content
Log in

Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report

  • Case Report
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

Danazol, an inhibitor of pituitary gonadotropin with weak androgenic effect, is currently being used for the treatment of endometriosis. In contrast to other C17 alkylated anabolic steroids, it has been rarely associated with the occurrence of primary liver tumors. We present the case of a patient with endometriosis in whom a hepatocellular adenoma was discovered after 14 years of treatment with danazol for endometriosis. The patient showed no clinical signs of a liver tumor and it was only detected by ultrasonography and magnetic resonance imaging (MRI). When long-term danazol therapy is required, regular ultrasonography for monitoring and early tumor detection is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Barbieri RL, Ryan KJ (1981) Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 15:453–463

    Article  Google Scholar 

  2. Baum JK, Bookstein JJ, Holtz F, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 27:926–929

    Article  Google Scholar 

  3. Boue F, Coffin B, Delfraissy JF (1986) Danazol and cholestatic hepatitis. Ann Intern Med 105:139–140

    Article  CAS  PubMed  Google Scholar 

  4. Bork K, Schneiders V (2002) Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol 36:707–709

    Article  PubMed  Google Scholar 

  5. Bork K, Pitton M, Harten P, Koch P (1999) Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 27:1066–1067

    Article  Google Scholar 

  6. Buamah PK (1985) An apparent Danazol induced primary hepatocellular carcinom: case report. J Surg Oncol 28:114–116

    Article  CAS  PubMed  Google Scholar 

  7. Bühler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M (1982) Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82:775–782

    Article  PubMed  Google Scholar 

  8. Chevalier X, Awada H, Baetz A, Amor B (1990), Danazol induced pancreatitis and hepatitis. Clin Rheumatol 9:239–241

    Article  CAS  PubMed  Google Scholar 

  9. Crampon D, Barnoud R, Durand M, Ponard D, Jacquot C, Sotto JJ, Letoublon C, Zarski JP (1998) Danazol therapy: an unusual aetiology of hepatocellular carcinoma. J Hepatol 29:1035–1036

    Article  CAS  PubMed  Google Scholar 

  10. de Menis E, Tramonti P, Conte N (1999) Danazol and multiple hepatic adenomas: peculiar clinical findings in an acromegalic patient. Horm Metab Res 31:476–477

    Article  PubMed  Google Scholar 

  11. Dmowski WP (1990) Danazol. A sythetic steroid with diverse biologic effects. J Reprod Med 35 [Suppl 1]:69–74

    CAS  PubMed  Google Scholar 

  12. Edmondson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86:180–182

    Article  CAS  PubMed  Google Scholar 

  13. el-Roeiy A, Dmowski WP, Gleicher N, Radwanska E, Harlow L, Binor Z, Tummon I, Rawlins RG (1988) Danazol but not gonadotrophin releasing hormone agonists suppresses auto antibodies in endometriosis. Fertil Steril 50:864–871

    Article  CAS  PubMed  Google Scholar 

  14. Fremand JP, Levy Y, Bouscary D, D'Agay MF, Clot P, Frija J, Brouet JC (1990) Danazol-induced hepatocellular adenoma. Am J Med 88:529–530

    Article  Google Scholar 

  15. Ishak KG (1988) Benign tumors and pseudotumors of the liver. Appl Pathol 6:82–104

    CAS  PubMed  Google Scholar 

  16. Ishak KG, Zimmerman HJ (1987) Hepatotoxic effects of the anabolic/androgenic steroids. Sem Liver Dis 7:230–236

    Article  CAS  Google Scholar 

  17. Ishak KG, Zachary DG, Stocker JT (2001) Benign hepatocellular tumors. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, third series. Armed Forces Institute of Pathology, Waschington DC, pp 9–48

  18. Kahn H, Manzarbeitia C, Theise N, Schwartz M, Miller C, Thing SN (1991) Danazol induced hepatocellular adenomas. A case report and review of literature. Arch Pathol Lab Med 115:1054–1057

    CAS  PubMed  Google Scholar 

  19. Makdisi WJ, Cherian R, Vanveldhuizen PJ, Talley RL, Stark SP, Dixon AY (1995) Fatal peliosis on the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol. Am J Gastroenterol 90:317–318

    CAS  PubMed  Google Scholar 

  20. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, Dhumeaux D (2000) Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 118:560–564

    Article  CAS  PubMed  Google Scholar 

  21. Middleton C, McCaughan GW, Painter DM., Stephen MS, Beale M, Fraser I (1989) Danazol and hepatic neoplasia: a case report. Aust NZ J Med 19:733–734

    Article  CAS  Google Scholar 

  22. Nesher G, Dollberg L, Zimran A, Hershko C (1985) Hepatosplenic peliosis after danazol and glucocorticoids for ITP. N Engl J Med 24:242–243

    Google Scholar 

  23. Oberti F, Drouet D'Aubigny N, Farges O, Cales P (1994) Adenome haptocellulaire chez une femme après prise de danazol. Gastoenterol Clin Biol. 18:902–903

    CAS  Google Scholar 

  24. Pearson K, Zimmerman HJ (1980) Danazol and liver damage. Lancet 22:645–646

    Article  Google Scholar 

  25. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) The Cooperative Liver Tumor Study Group: epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–648

    Article  CAS  PubMed  Google Scholar 

  26. Veit V, Hardwisgen J, Bernit E, Gachon J, Kaplanski G, Schlienger JL (1999) Traintment par danazol, une étiologie exceptionelle d'hépatocarcinome: à prospos d'une observation. Rev Méd Intern 20:6346

    Google Scholar 

  27. Vincens M, Athea N, Dougados M, Jungers P (1984) Increase in transaminase levels during treatment with danazol in lupus patients. Therapie 39:541–544

    CAS  PubMed  Google Scholar 

  28. Weill BJ, Menkes CJ, Cormier C, Louvel A, Dougados M, Houssin D (1988) Hepatocellular carcinoma after danazol therapy. J Rheumatol 15:1447–49

    CAS  PubMed  Google Scholar 

  29. Zurlo JJ, Frank MM (1990) The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 54:64–72

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartley, J., Loddenkemper, C., Lange, J. et al. Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report. Arch Gynecol Obstet 269, 290–293 (2004). https://doi.org/10.1007/s00404-002-0435-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-002-0435-z

Keywords.

Navigation